Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Lopinavir And Ritonavir (Atc Code: J05Ar10).

AOK Niedersachsen. Die Gesundheitskasse. Germany has Released a tender for Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Lopinavir And Ritonavir (Atc Code: J05Ar10). in Pharmaceuticals. The tender was released on Aug 08, 2024.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Lopinavir And Ritonavir (Atc Code: J05Ar10).

Deadline - Jul 28, 2026

MT reference number - 90373667

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 90373667

  Document Type - Tender Notices

Login

Notice Details and Documents:

Description - Description: Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient combination of lopinavir and ritonavir (ATC code: J05AR10) within the period from October 1, 2024 to September 30, 2026 with the possibility of concluding the contract at any time during the term (“open-house model”).notice_title: Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Lopinavir And Ritonavir (Atc Code: J05Ar10).notice_contract_type: Goodslocal_description: Abschluss eines nicht exklusiven Rabattvert

Mt Ref Id - 90373667

Deadline - Jul 28, 2026

Login

Share

View more tenders for

Pharmaceuticals Tenders Pharmaceutical products Tenders Germany Tenders

Similar Tenders :

Most Searched